In addition to the PD-related state, lowering LRRK2 kinase activity has been shown to have anti-inflammatory properties even in a mouse model with spinal cord injury [27], thus supporting the idea that LRRK2 could be targeted and be beneficial for different brain diseases with an inflammatory component. The gene discussed is LRRK2; the disease is Parkinson disease.